| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 03/16/2000 | CA2341782A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 03/16/2000 | CA2341349A1 Attenuated cells comprising sp12 mutants, carriers and compositions containing same, methods of production and uses thereof |
| 03/15/2000 | EP0985732A2 Trimeric chimera protein and collagen matrix containing chimera protein |
| 03/15/2000 | EP0985047A2 Somatic gene therapy to suppress secondary cataract formation |
| 03/15/2000 | EP0434721B1 Viral nucleotide sequences |
| 03/15/2000 | CN1050302C Chicken anaemia agent vaccine |
| 03/14/2000 | US6037456 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/14/2000 | US6037348 Inhibition of viral replication |
| 03/14/2000 | US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby |
| 03/14/2000 | CA2098483C Safe adeno-associated virus 2 vector for gene therapy |
| 03/09/2000 | WO2000012765A1 Method for assessing the relative purity of viral gene transfer vector stocks |
| 03/09/2000 | WO2000012741A2 Inducible expression system |
| 03/09/2000 | WO2000012740A2 ADENOVIRUSES DELETED IN THE IVa2, 100K AND/OR PRETERMINAL PROTEIN SEQUENCES |
| 03/09/2000 | WO2000012739A1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors |
| 03/09/2000 | WO2000012738A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | WO2000012684A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 03/09/2000 | WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/09/2000 | WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/09/2000 | WO1999063063A8 Cellular proteins which mediate herpesvirus entry |
| 03/09/2000 | DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine |
| 03/09/2000 | CA2341775A1 Inducible expression system |
| 03/09/2000 | CA2341627A1 Method for assessing the relative purity of viral gene transfer vector stocks |
| 03/09/2000 | CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes |
| 03/09/2000 | CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation |
| 03/09/2000 | CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences |
| 03/09/2000 | CA2336961A1 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus |
| 03/08/2000 | EP0656062B1 Dorsal tissue affecting factor and compositions |
| 03/08/2000 | CN1246800A Infectious bursits vaccine |
| 03/07/2000 | US6033908 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 03/07/2000 | US6033905 Gibbon ape leukemia virus-based retroviral vectors |
| 03/07/2000 | US6033904 Recombinant swinepox virus |
| 03/07/2000 | US6033895 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/07/2000 | US6033886 Recombinant infectious non-segmented negative strand RNA virus |
| 03/07/2000 | US6033885 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
| 03/07/2000 | US6033844 Porcine reproduction respiratory syndrome diagnostic |
| 03/07/2000 | US6033671 Identification of human cytomegalovirus genes involved in down-regulation of MHC class I heavy chain expression |
| 03/07/2000 | US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus |
| 03/02/2000 | WO2000011202A1 Cationic complexes of polymer-modified adenovirus |
| 03/02/2000 | WO2000011201A1 Targeted alphavirus and alphaviral vectors |
| 03/02/2000 | WO2000011154A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
| 03/02/2000 | WO2000011151A2 Direct oviduct transgenesis |
| 03/02/2000 | WO2000011149A1 Methods of producing high titer recombinant adeno-associated virus |
| 03/02/2000 | CA2341516A1 Cationic complexes of polymer-modified adenovirus |
| 03/02/2000 | CA2340335A1 Use of suppressor trna's to regulate cytotoxicity during the production of recombinant gene products |
| 03/02/2000 | CA2337905A1 Targeted alphavirus and alphaviral vectors |
| 03/01/2000 | EP0982405A2 Recombinant alphavirus vectors |
| 03/01/2000 | EP0981636A1 Lentivirus-based gene transfer vectors |
| 03/01/2000 | EP0981601A1 Methods for cultivating cells and propagating viruses |
| 03/01/2000 | EP0981537A1 An infectious clone for human parainfluenza virus type 3 |
| 03/01/2000 | EP0981511A1 Methods and compositions for the selective modification of nucleic acids |
| 02/29/2000 | US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics |
| 02/29/2000 | US6030769 Strains of human immunodeficiency virus; for use as sensitive diagnositic agents and immunogenic compositions |
| 02/29/2000 | US6030626 Method for preparing the fimbrin protein of Haemophilus influenzae |
| 02/29/2000 | CA2182207C Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 02/24/2000 | WO2000009730A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 02/24/2000 | WO2000009713A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | WO2000009703A1 Hiv vaccine |
| 02/24/2000 | WO2000009702A1 Cold-adapted equine influenza viruses |
| 02/24/2000 | WO2000009700A1 Rna virus vector having contact infiltration capability |
| 02/24/2000 | WO2000009699A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO1999054441A8 Efficient purification of adenovirus |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | CA2339779A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 02/24/2000 | CA2280582A1 Compositions and methods for protecting animals from lentivirus-associated disease such as feline immunodeficiency virus |
| 02/22/2000 | US6027931 Adeno-associated virus (aav) helper functions that produce low amounts of the long form of aav rep (replication) proteins, resulting in high-efficiency production of recombinant aav |
| 02/22/2000 | US6027930 New mutant filamentous helper phage which has retained the gene iii promoter, whereas the gene iii encoding sequence is deleted; used for selection of specific binding proteins and their genes in phage display techniques |
| 02/22/2000 | CA2063303C Preparation of virus-free immunoglobulins |
| 02/22/2000 | CA1340910C Fibronectin binding protein |
| 02/22/2000 | CA1340906C Fibronectin binding protein as well as its preparation |
| 02/17/2000 | WO2000008469A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/17/2000 | WO2000008194A2 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | WO2000008193A2 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008182A1 Herpesvirus preparations and their uses |
| 02/17/2000 | WO2000008165A1 Attenuated equine herpesvirus |
| 02/17/2000 | WO2000008131A2 Pseudotyped retroviruses and stable cell lines for their production |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | WO1999061601A3 Aav5 vector and uses thereof |
| 02/17/2000 | WO1999060110A9 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2337968A1 Herpesvirus preparations and their uses |
| 02/17/2000 | CA2337963A1 Latency-active regulatory sequences of herpesviruses and latency-inactive herpesvirus for gene transfer |
| 02/17/2000 | CA2336592A1 Cell lines for the propagation of mutated herpes viruses |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | CA2328494A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0979093A1 Arrestable therapeutic viral agent |
| 02/16/2000 | CN1244896A Non-M, non-O, HIV-1 strains, fragments and applications |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025182 Method for producing a virus from an african green monkey kidney cell line |
| 02/15/2000 | US6025163 DNA coding for a peptide of a papilloma virus main capside protein and use thereof |
| 02/15/2000 | US6025125 Methods for the detection of HIV-specific immune responses employing non-infectious, non-replicating, IIV retrovirus-like particles containing heterologous antigenic markers |
| 02/15/2000 | US6024962 Mercaptan gene and amine terminus with amine acid nucleic acid sequence |
| 02/15/2000 | US6024953 Prevention of rabies in mammals, administering a hybrid vaccine |